TCTAP A-149 Clinical Outcome of Drug-Eluting Stent Implantation for Isolated Left Circumflex Ostial Stenosis  by Tsutsumi, Masakazu et al.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 5 , N O . 1 7 , S U P P L S , 2 0 1 5 S71At one year follow up targer lesion revascularization (7.3% vs. 3.1%,
p¼0.11), subsequent CABG (2.1% vs. 2.5%, p¼0.59) and all-cause mor-
tality (0.5% vs. 1.25%, p¼0.51) were statistically similar in both groups.
CONCLUSION Precise stent placement may be difﬁcult in complex
LAD ostium lesion due to unwanted movement & angulation.
Simultaneous balloon placement is technically simple approach for
prevention of unwanted stent movement.
Keeping balloon in LM to LCX during LAD ostial stent placement is
very much helpful & can be applied in clinical practice. Operator
should also consider 7 Fr guiding catheter, Superzooming, RAO caudal
or LAO caudal view, DES stent with high radial force.
Our technique is quick, effective and technically simple for precise
stent placement at LAD ostium. Present data also support this unique,
innovative & simple technique. Further large scale studies into the
optimal LAD ostial stenting are warranted to establish this technique.DRUG-ELUTING STENTS (TCTAP A-148 TO TCTAP A-152)
TCTAP A-148
Comparison of Predictors of Stent Thrombosis Between 1st Generation and
2nd Generation Drug-Eluting Stents Deployment in Patients with Acute
Myocardial Infarction
Jong Yop Pae,1 Seung-Ho Hur,1 Chang-Wook Nam,1 Hyuck Jun Yoon,1
Yun-Kyeong Cho,1 Kwon-Bae Kim1
1Keimyung University Dongsan Medical Center, Korea (Republic of)
BACKGROUND Although drug-eluting stents (DES) markedly reduced
the incidence of in-stent restenosis (ISR), the risk of the stent
thrombosis (ST) cannot be ignored. In previous studies, comparison of
predictors of ST between bare metal stent and DES were studied
mainly. The aim of this study was to evaluate the differences of pre-
dictors of ST between 1stgeneration and 2nd generation DES after
percutaneous coronary intervention (PCI).
METHODS 2117 patients who underwent PPCI due to acute myocardial
infarction were enrolled since January 2006 to December 2013. The
1stgeneration drug-eluting stent (DES) included the Cypher and Taxus.
The 2ndgeneration DES included Resolute, Xience and Promus.
RESULTS ST was shown in 39 patients (1.84%). 1st generation DES
was used in 30 patients (30/1084 ¼ 2.8%) and 2nd generation DES was
used in 9 patients (9/1033 ¼ 0.9%). Patients who used 1st generation
DES showed signiﬁcantly higher ST rate compared with patients who
used 2nd generation DES (p 0.001). In patients treated with 1st gen-
eration DES, younger age (RR 0.956, CI 0.926-0.987, p¼0.006) and
hypertension (2.494, 1.136-5.478, 0.023) were associated with the
increased risk of stent thrombosis. In patients treated with 2nd gen-
eration DES, younger age (0.888, 0.828-0.952, 0.001), lower ejection
fraction (0.904, 0.842-0.970, 0.005), multi stent (5.676, 1.255-25.671,
0.024) were associated with the increased risk of ST.
CONCLUSION Patients who treated with 1st generation DES showed
higher incidence rate of ST compared with 2nd generation DES. Although
there were similar independent predictors of ST for both DES such as
younger age, there were also different predictors as hypertension for 1st
generation DES and lower ejection fraction for 2nd generation DES.TCTAP A-149
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BACKGROUND Clinical outcome of the intervention for isolated left
circumﬂex (LCx) ostial lesion is uncertain. The aim of this study is to
investigate the outcomes of ﬁrst and second generation drug-eluting
stent (DES) implantation for isolated LCx ostial disease.
METHODS This is a single center, retrospective study. Between April
2007 and March 2013, a total of 10755 percutaneous coronary in-
terventions (PCI) were performed in our hospital. Among these, we
performed elective DES implantation for 77 stable patients with iso-
lated LCx ostial lesions. 19 Sirolimus-eluting stents and 15 Paclitaxel-
eluting stents were implanted. (34 patients in ﬁrst generation group)
10 Zotarolimus-eluting stents, 25 Everolimus-eluting stents and 8
Biolimus A9-eluting stents were implanted. (43 patients in second
generation group) We evaluated their backgrounds and clinical out-
comes. The end points were the occurrence of major adverse cardiac
events (MACE) and target lesion revascularization (TLR).
RESULTS First and second generation groups were followed up for
1359669 days and 900454 days. Backgrounds are similar in
2groups. Kaplan-Meier survival curves showed that freedom from
MACE and TLR at 2years were 82.4% and 86.7% in second generation
group, compared with 78.4% and 84.3% in ﬁrst generation group.
(p¼0.53 and p¼0.43).
CONCLUSION Second generation DES offers no statistically signiﬁ-
cant advantage over ﬁrst generation DES in middle-term outcome of
PCI for isolated LCx ostial stenosis.
